Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Viehbacher's supposed failings: from Brazil to Phoenix via Lantus

This article was originally published in Scrip

Executive Summary

It wasn't because he wasn't French enough: failings in execution and communication with the board led to his departure. That is the essence of the message coming from Sanofi over the shock sacking of its CEO Chris Viehbacher by the unanimous decision of its board of directors. The removal was precipitated by media leaks, but had been under consideration since the summer, the company confirmed.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts